Member access

4-Traders Homepage  >  Shares  >  Stock Exchange of Hong Kong  >  Shandong Weigao Group Medical Polymer Co       CNE100000171

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Shandong Weigao Group Medi : Income Statement Evolution
Annual Income Statement Data
Actuals in M CNY Estimates in M CNY
Fiscal Period December 201020112012201320142015
Sales2 4633 1813 6894 5615 5456 598
Operating income (EBITDA)9911 1329831 3431 6552 033
Operating profit (EBIT)8921 0358551 1751 4601 749
Pre-Tax Profit (EBT)8883 5931 1261 3631 6682 063
Net income7993 4629961 2031 4721 815
EPS ( CNY)0,190,780,220,270,320,39
Dividend per Share ( CNY)0,050,060,070,070,090,09
Yield0,82%0,92%1,03%1,11%1,36%1,47%
Announcement Date03/15/2011
01:29pm
03/15/2012
09:13am
03/25/2013
02:56pm
---
Finances - Leverage
Shandong Weigao Group Medi : Finances - Leverage
Actuals in M CNY Estimates in M CNY
Fiscal Period December 201020112012201320142015
Debt------
Finance5141 7671 2981 3821 7942 275
Operating income (EBITDA)9911 1329831 3431 6552 033
Leverage
(Debt/EBITDA)
------
Capital Expenditure3391 136864668557543
Book Value Per Share (BVPS)0,84  CNY1,83  CNY1,99  CNY2,11  CNY2,35  CNY2,73  CNY
Cash Flow per Share0,12  CNY0,14  CNY0,18  CNY0,24  CNY0,35  CNY0,40  CNY
Announcement Date03/15/2011
01:29pm
03/15/2012
09:13am
03/25/2013
02:56pm
---
Balance Sheet Analysis
Shandong Weigao Group Medi : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 28 729 M CNY -
Company Value 27 347 M CNY 26 935 M CNY
Valuation 2013e 2014e
PER (Price / EPS) 24,1x 19,8x
Capitalization / Revenue 6,30x 5,18x
EV / Revenue 6,00x 4,86x
EV / EBITDA 20,4x 16,3x
Yield (DPS / Price) 1,11% 1,36%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 25,8% 26,3%
operating laverage (Delta EBIT / Delta Sales) 1,59x 1,12x
Net Margin (Net Profit / Revenue) 26,4% 26,5%
ROA (Net Profit / Asset) 11,2% 12,6%
ROE (Net Profit / Equities) 12,9% 14,1%
Rate of Dividend 26,6% 27,0%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   14,6% 10,0%
Cash Flow / Sales (Taux d'autofinancement) 23,5% 27,9%
Capital Intensity (Assets / Sales) 2,36x 2,11x
Financial Leverage (Net Debt / EBITDA) -1,03x -1,08x
Price Earning Ratio
Shandong Weigao Group Medi : Price Earning Ratio
EPS & Dividend
Shandong Weigao Group Medi : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.